Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma.
Capone E, Perrotti V, Cela I, Lattanzio R, Togni L, Rubini C, Caponio VCA, Lo Muzio L, Colasante M, Giansanti F, Ippoliti R, Iacobelli S, Wick MJ, Spardy Burr N, Sala G.
Capone E, et al. Among authors: sala g.
Oral Oncol. 2024 Jan;148:106635. doi: 10.1016/j.oraloncology.2023.106635. Epub 2023 Nov 21.
Oral Oncol. 2024.
PMID: 37988837
Free article.